Investor Presentation October 2022
Powered by Technology.
Built by Doctors.
For Patients.
Forward-looking statements
This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward-looking statements include any statements about the Company's business, financial condition, operating results, plans, objectives, expectations and intentions, expansion plans, integration of acquired companies and any projections of earnings, revenue, EBITDA, Adjusted EBITDA or other financial items, such as the Company's projected capitation and future liquidity, and may be identified by the use of forward-looking terms such as "anticipate," "could," "can," "may," "might," "potential," "predict," "should," "estimate," "expect," "project," "believe," "plan," "envision," "intend," "continue," "target," "seek," "will," "would," and the negative of such terms, other variations on such terms or other similar or comparable words, phrases or terminology. Forward-looking statements reflect current views with respect to future events and financial performance and therefore cannot be guaranteed. Such statements are based on the current expectations and certain assumptions of the Company's management, and some or all of such expectations and assumptions may not materialize or may vary significantly from actual results. Actual results may also vary materially from forward-looking statements due to risks, uncertainties and other factors, known and unknown, including the risk factors
described from time to time in the Company's reports to the
limitation the risk factors discussed in the Company's Annual Report on Form 10-K for the year ended
Because the factors referred to above could cause actual results or outcomes to differ materially from those expressed or implied in any forward-looking statements, you should not place undue reliance on any such forward-looking statements. Any forward-looking statements speak only as of the date of this presentation and, unless legally required, the Company does not undertake any obligation to update any forward-looking statement, as a result of new information, future events or otherwise.
2
Key acronyms
- ACO:
Accountable Care Organization - ACO REACH: Accountable Care Organization Realizing Equity, Access, and
Community Health - AIPBP: All-InclusivePopulation-Based Payments
- APC: Allied Physicians of California IPA
- CMMI:
Centers for Medicare and Medicaid Innovation Center - CMS:
Centers for Medicare & Medicaid Services - DC:
Direct Contracting - DCE: Direct Contracting Entity
- DME: Durable Medical Equipment
- Health Plan / Payers: Health Insurance Companies
- HMO:
Health Maintenance Organization - IPA:
Independent Practice Association - NCI: Non-Controlling Interest
- NMM:
Network Medical Management, Inc. - MSA: Master Service Agreement
- MSO:
Management Services Organization - NGACO:
Next Generation Accountable Care Organization - PCP: Primary Care Physician
- PMPM: Per Member Per Month
- SNF: Skilled Nursing Facility
- VIE: Variable Interest Entity
3
ApolloMed investment highlights
1. Proven model for 25+ years with demonstrable clinical outcomes across all populations
• MA, Managed Medicaid, Commercial, ACA Exchange, Medicare FFS, etc.
2. Large and growing TAM with significant whitespace ahead across market segments (see slide 10)
Focus on aligning with and helping independent providers win
3. • Help them achieve the same scale and outcomes as an integrated delivery system
• Unlocks differentiated independent provider market
4. Proprietary technology platform with data moat, custom built for providers
5. Multiple drivers for growth with a scalable and repeatable playbook led by differentiated leadership team
6. Industry-leading unit economics - growing revenue at 38% YoY(1) profitably while maintaining positive EBITDA margins
(1) ApolloMed YE2021 to mid-point of YE2022E revenue growth
4
ApolloMed at-a-glance
Apollo Medical Holdings ("ApolloMed") is a leading physician-centric, technology- powered, risk-bearing healthcare company- Our end-to-end technology solutions enable providers to succeed in value-based care arrangements where they "quarterback" patient care to deliver better outcomes
- We manage over 1.2M lives through a network of 14 IPAs and 9,800+ contracted physicians, working with 20+ payer partners
- We have a 25+ year track record of profitable growth in our core geographic areas and a comprehensive strategy to grow nationally
1.2M+
Managed lives
9,800+
Contracted physicians
66%(1)
Fewer hospital admits per
1,000 vs. benchmark
$186M(2,3)
TTM adj. EBITDA
20+
Payer partners
71%(1)
Fewer ER visits per 1,000 vs. benchmark
$955M(3)
TTM revenue
10-15%
Long-term EBITDA margin
Source: CMS,
Note: Information as of
- Internal Medicare patient data from consolidated IPAs from
Jan 2021 -Sept 2021 ; (2) See "Reconciliation of Net Income to EBITDA and Adjusted EBITDA" and "Use of Non-GAAP Financial Measures" slides for more information; (3) TTM as of6/30/2022
5
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Disclaimer
Ian insured losses near $4.5 billion
Insurance Market to Witness Massive Growth by 2028 : Allianz, Berkshire Hathaway, Manulife Financial: Insurance Market Analysis & Forecast for Next 5 Years
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News